nanoTherics Launches the magneTherm™
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
nanoTherics has announced launch of the magneTherm™, a new device designed to measure thermal effects of magnetic nanoparticles for hyperthermia applications.
The system is totally and is the only commercially available hyperthermia device available for measuring these thermal effects that includes flexibility in frequency selection.
nanoTherics’s primary business is supply of scientific devices and associated products to research laboratories in the pharmaceutical and biotechnology industries as well as academia.
The Company’s main products follow from >30 years combined research into magnetic nanoparticle use conducted at Keele University and University of Florida and apply a patent-pending technology using nanoparticles and magnetic fields to facilitate enhanced delivery of biomolecules, such as DNA, into living cells.
Dr Linda Cammish, Chief Executive Officer, said, “We are delighted to launch the magneTherm”. She added, “It follows our March 2009 launch of the magneFect-nano which uses proprietary oscillating magnetic arrays to promote particle/DNA uptake into cells to improve gene transfection whilst maintaining cell viability The introduction of these systems is illustrative of our expertise in magnetic nanoparticle technology for a range of life science research and human health applications, in the emerging field of nanomedicine arena and shows our commitment to product development to meet customer’s needs.”
The system is totally and is the only commercially available hyperthermia device available for measuring these thermal effects that includes flexibility in frequency selection.
nanoTherics’s primary business is supply of scientific devices and associated products to research laboratories in the pharmaceutical and biotechnology industries as well as academia.
The Company’s main products follow from >30 years combined research into magnetic nanoparticle use conducted at Keele University and University of Florida and apply a patent-pending technology using nanoparticles and magnetic fields to facilitate enhanced delivery of biomolecules, such as DNA, into living cells.
Dr Linda Cammish, Chief Executive Officer, said, “We are delighted to launch the magneTherm”. She added, “It follows our March 2009 launch of the magneFect-nano which uses proprietary oscillating magnetic arrays to promote particle/DNA uptake into cells to improve gene transfection whilst maintaining cell viability The introduction of these systems is illustrative of our expertise in magnetic nanoparticle technology for a range of life science research and human health applications, in the emerging field of nanomedicine arena and shows our commitment to product development to meet customer’s needs.”
